Data-Driven Mathematical Modeling and Dynamical Analysis for SARS-CoV-2 Coinfection with Bacteria

The ongoing coronavirus disease-2019 (COVID-19) pandemic caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has serious influences on human health and economy. The available clinical data suggest that patients infected by SARS-CoV-2 have the possibility of simultaneous infection of bacteria. In this study, we present a data-driven mathematical model for coinfection of SARS-CoV-2 and bacteria to investigate the dynamics of COVID-19 progress. Specifically, based on the statistical analysis of different clinical data from China and some other countries, a system model with ordinary differential equations (ODEs) in four variables, i.e. SARS-CoV-2, bacteria, neutrophils and lymphocytes, is established. We further validate our model through theoretical analysis and fitting of different clinical data. Moreover, through numerical simulations and bifurcation analysis, we find that bacterial infection and immune-related parameters in certain ranges lead to the system transitions among three steady states, i.e. mild, severe and death. We also analyzed the influence of the time it takes for patients to switch from a high-risk area to a low-risk area on the recovery time. These results reveal that the coinfection of viruses and bacteria can explain the changes in neutrophils and lymphocytes, and that initial bacterial infection and immune-related parameters have great influences on the severity degree and mortality in COVID-19 patients. Together, our model and quantitative analysis suggest that preventing bacterial infection and enhancing immune ability during the early phase of infections could be a potential treatment option for high-risk COVID-19 patients.

[1]  Tangchun Wu,et al.  Reconstruction of the full transmission dynamics of COVID-19 in Wuhan , 2020, Nature.

[2]  P. Rieu,et al.  Neutrophils: Molecules, Functions and Pathophysiological Aspects , 2000, Laboratory Investigation.

[3]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[4]  Yang Kuang,et al.  Dynamics of a delay differential equation model of hepatitis B virus infection , 2008, Journal of biological dynamics.

[5]  W. Liles,et al.  The phagocytes: neutrophils and monocytes. , 2008, Blood.

[6]  Johannes Zierenberg,et al.  Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions , 2020, Science.

[7]  Yuxiao Song,et al.  Clinical characteristics of 82 cases of death from COVID-19 , 2020, PloS one.

[8]  F. Rombouts,et al.  Modeling of the Bacterial Growth Curve , 1990, Applied and environmental microbiology.

[9]  France Gauvin,et al.  Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  S. Perlman,et al.  COVID-19 Treatments and Pathogenesis Including Anosmia in K18-hACE2 mice , 2020, Nature.

[11]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[12]  Judit Zsuga,et al.  The Hill equation and the origin of quantitative pharmacology , 2012 .

[13]  Edda Klipp,et al.  Systems Biology in Practice , 2005 .

[14]  Bharath Srinivasan,et al.  Words of advice: teaching enzyme kinetics , 2020, The FEBS journal.

[15]  Carl Nathan,et al.  Neutrophils and immunity: challenges and opportunities , 2006, Nature Reviews Immunology.

[16]  Uri Alon,et al.  An Introduction to Systems Biology , 2006 .

[17]  W. Wang,et al.  Viral and host factors related to the clinical outcome of COVID-19 , 2020, Nature.

[18]  Shamus P. Keeler,et al.  SARS-CoV-2 infection of hACE2 transgenic mice causes severe lung inflammation and impaired function , 2020, Nature Immunology.

[19]  Eric Song,et al.  Longitudinal analyses reveal immunological misfiring in severe COVID-19 , 2020, Nature.

[20]  Roland Eils,et al.  COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis , 2020, Nature Biotechnology.

[21]  Akiko Iwasaki,et al.  Innate immunity to influenza virus infection , 2014, Nature Reviews Immunology.

[22]  Theodora Psaltopoulou,et al.  Hematological findings and complications of COVID‐19 , 2020, American journal of hematology.

[23]  J. M. Crawford,et al.  Targeting potential drivers of COVID-19: Neutrophil extracellular traps , 2020, The Journal of experimental medicine.